Showing results (301-310 of 311) with videos related to

Sort By:
Pageof 32
Clinical Medicine (London, England)|May 17, 2020
Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related diseaseGeorge Goodchild, Rory Jr Peters, Tamsin N Cargill, et al.
Marine Pollution Bulletin|February 3, 2023
Relationship between in feed drugs, antibiotics and organic enrichment in marine sediments at Canadian Atlantic salmon aquaculture sitesM V Kingsbury, D Hamoutene, P Kraska, et al.
Bioorganic & Medicinal Chemistry|December 13, 2018
The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of painAlan D Brown, Sharan K Bagal, Paul Blackwell, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Discovery and Optimization of Selective Nav1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of PainSharan K Bagal, Peter J Bungay, Stephen M Denton, et al.
ACS Pharmacology & Translational Science|August 25, 2020
Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 ReceptorParis Avgoustou, Ameera B A Jailani, Jean-Olivier Zirimwabagabo, et al.
Journal of Medicinal Chemistry|April 20, 2018
Discovery of Allosteric, Potent, Subtype Selective, and Peripherally Restricted TrkA Kinase InhibitorsSharan K Bagal, Kiyoyuki Omoto, David C Blakemore, et al.
Pharmaceutical Research|April 27, 2007
AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectivesChandra S Chaurasia, Markus Müller, Edward D Bashaw, et al.
Journal of Medicinal Chemistry|June 1, 2014
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT₂C) receptor agonists with exquisite functional selectivity over 5-HT₂A and 5-HT₂B receptorsR Ian Storer, Paul E Brennan, Alan D Brown, et al.
British Journal of Pharmacology|January 28, 2015
A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitabilityClaire Elizabeth Payne, Adam R Brown, Jonathon W Theile, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinenceMark D Andrews, Paul V Fish, Julian Blagg, et al.
Pageof 32